AFT Pharmaceuticals has increased its Australian presence with its own dedicated sales team of representatives visiting doctors and pharmacists.
Strong sales growth (+50% p.a.) continues in the Australian market fueled by new product introductions and growth of existing products.
May 1, 2024
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….